Assessment of pulmonary lesions with 18F-fluorodeoxyglucose positron imaging using coincidence mode gamma cameras

Wolfgang Weber, Carter Young, Hussein M. Abdel-Dayem, George Sfakianakis, G. John Weir, Charles M. Swaney, Mark Gates, Marcel P. Stokkel, Anthony Parker, Horace Hines, Behrouz Khanvali, John R. Liebig, Ann N. Leung, Richard Sollitto, Gary R Caputo, Henry N. Wagner

Research output: Contribution to journalArticle

72 Citations (Scopus)

Abstract

Accurate assessment of lung carcinoma remains a significant clinical problem, often leading to surgical procedures without curative potential. PET with 18F-fluorodeoxyglucose (FDG) has shown promise in differentiating benign from malignant lesions and in staging the extent of disease, resulting in improved treatment at a significant cost savings. This multicenter prospective study used dual-detector coincidence imaging with FDG to categorize pulmonary lesions as benign or malignant. The goal of this study was to determine the sensitivity and specificity of dual-detector coincidence imaging of FDG in patients with pulmonary lesions who were scheduled to have a diagnostic procedure for histopathologic confirmation. Methods: A total of 96 patients with pulmonary lesions with a lesion size ranging from 1 to 7 cm with a mean of 3.44 cm based on their chest radiograph or CT scan were studied using FDG scans with a dual-detector coincidence detection system. An additional 24 patients were entered as control subjects. The studies of 120 subjects were interpreted in random order by three physicians experienced in the use of FDG in patients with lung cancer. Surgical pathology was used as the standard for identifying malignant lesions. Results: There was 94% agreement between the readers in the independent interpretation of the FDG studies. In the 96 patients with pulmonary lesions, FDG studies were 97% sensitive and 80% specific in identifying proven malignant lesions. Conclusion: The results of this prospective study provide evidence that dual- detector coincidence imaging with FDG provides an accurate, sensitive and specific means of diagnosing malignancy in patients with pulmonary lesions.

Original languageEnglish (US)
Pages (from-to)574-578
Number of pages5
JournalJournal of Nuclear Medicine
Volume40
Issue number4
StatePublished - Apr 1999
Externally publishedYes

Fingerprint

Gamma Cameras
Fluorodeoxyglucose F18
Electrons
Lung
Prospective Studies
Surgical Pathology
Cost Savings
Multicenter Studies
Lung Neoplasms
Thorax
Carcinoma
Physicians
Sensitivity and Specificity
Neoplasms

Keywords

  • F-fluorodeoxyglucose
  • Dual-detector coincidence imaging
  • Solitary pulmonary lesions

ASJC Scopus subject areas

  • Radiological and Ultrasound Technology

Cite this

Weber, W., Young, C., Abdel-Dayem, H. M., Sfakianakis, G., Weir, G. J., Swaney, C. M., ... Wagner, H. N. (1999). Assessment of pulmonary lesions with 18F-fluorodeoxyglucose positron imaging using coincidence mode gamma cameras. Journal of Nuclear Medicine, 40(4), 574-578.

Assessment of pulmonary lesions with 18F-fluorodeoxyglucose positron imaging using coincidence mode gamma cameras. / Weber, Wolfgang; Young, Carter; Abdel-Dayem, Hussein M.; Sfakianakis, George; Weir, G. John; Swaney, Charles M.; Gates, Mark; Stokkel, Marcel P.; Parker, Anthony; Hines, Horace; Khanvali, Behrouz; Liebig, John R.; Leung, Ann N.; Sollitto, Richard; Caputo, Gary R; Wagner, Henry N.

In: Journal of Nuclear Medicine, Vol. 40, No. 4, 04.1999, p. 574-578.

Research output: Contribution to journalArticle

Weber, W, Young, C, Abdel-Dayem, HM, Sfakianakis, G, Weir, GJ, Swaney, CM, Gates, M, Stokkel, MP, Parker, A, Hines, H, Khanvali, B, Liebig, JR, Leung, AN, Sollitto, R, Caputo, GR & Wagner, HN 1999, 'Assessment of pulmonary lesions with 18F-fluorodeoxyglucose positron imaging using coincidence mode gamma cameras', Journal of Nuclear Medicine, vol. 40, no. 4, pp. 574-578.
Weber W, Young C, Abdel-Dayem HM, Sfakianakis G, Weir GJ, Swaney CM et al. Assessment of pulmonary lesions with 18F-fluorodeoxyglucose positron imaging using coincidence mode gamma cameras. Journal of Nuclear Medicine. 1999 Apr;40(4):574-578.
Weber, Wolfgang ; Young, Carter ; Abdel-Dayem, Hussein M. ; Sfakianakis, George ; Weir, G. John ; Swaney, Charles M. ; Gates, Mark ; Stokkel, Marcel P. ; Parker, Anthony ; Hines, Horace ; Khanvali, Behrouz ; Liebig, John R. ; Leung, Ann N. ; Sollitto, Richard ; Caputo, Gary R ; Wagner, Henry N. / Assessment of pulmonary lesions with 18F-fluorodeoxyglucose positron imaging using coincidence mode gamma cameras. In: Journal of Nuclear Medicine. 1999 ; Vol. 40, No. 4. pp. 574-578.
@article{900274ab497e4366a69aa96f755fef1f,
title = "Assessment of pulmonary lesions with 18F-fluorodeoxyglucose positron imaging using coincidence mode gamma cameras",
abstract = "Accurate assessment of lung carcinoma remains a significant clinical problem, often leading to surgical procedures without curative potential. PET with 18F-fluorodeoxyglucose (FDG) has shown promise in differentiating benign from malignant lesions and in staging the extent of disease, resulting in improved treatment at a significant cost savings. This multicenter prospective study used dual-detector coincidence imaging with FDG to categorize pulmonary lesions as benign or malignant. The goal of this study was to determine the sensitivity and specificity of dual-detector coincidence imaging of FDG in patients with pulmonary lesions who were scheduled to have a diagnostic procedure for histopathologic confirmation. Methods: A total of 96 patients with pulmonary lesions with a lesion size ranging from 1 to 7 cm with a mean of 3.44 cm based on their chest radiograph or CT scan were studied using FDG scans with a dual-detector coincidence detection system. An additional 24 patients were entered as control subjects. The studies of 120 subjects were interpreted in random order by three physicians experienced in the use of FDG in patients with lung cancer. Surgical pathology was used as the standard for identifying malignant lesions. Results: There was 94{\%} agreement between the readers in the independent interpretation of the FDG studies. In the 96 patients with pulmonary lesions, FDG studies were 97{\%} sensitive and 80{\%} specific in identifying proven malignant lesions. Conclusion: The results of this prospective study provide evidence that dual- detector coincidence imaging with FDG provides an accurate, sensitive and specific means of diagnosing malignancy in patients with pulmonary lesions.",
keywords = "F-fluorodeoxyglucose, Dual-detector coincidence imaging, Solitary pulmonary lesions",
author = "Wolfgang Weber and Carter Young and Abdel-Dayem, {Hussein M.} and George Sfakianakis and Weir, {G. John} and Swaney, {Charles M.} and Mark Gates and Stokkel, {Marcel P.} and Anthony Parker and Horace Hines and Behrouz Khanvali and Liebig, {John R.} and Leung, {Ann N.} and Richard Sollitto and Caputo, {Gary R} and Wagner, {Henry N.}",
year = "1999",
month = "4",
language = "English (US)",
volume = "40",
pages = "574--578",
journal = "Journal of Nuclear Medicine",
issn = "0161-5505",
publisher = "Society of Nuclear Medicine Inc.",
number = "4",

}

TY - JOUR

T1 - Assessment of pulmonary lesions with 18F-fluorodeoxyglucose positron imaging using coincidence mode gamma cameras

AU - Weber, Wolfgang

AU - Young, Carter

AU - Abdel-Dayem, Hussein M.

AU - Sfakianakis, George

AU - Weir, G. John

AU - Swaney, Charles M.

AU - Gates, Mark

AU - Stokkel, Marcel P.

AU - Parker, Anthony

AU - Hines, Horace

AU - Khanvali, Behrouz

AU - Liebig, John R.

AU - Leung, Ann N.

AU - Sollitto, Richard

AU - Caputo, Gary R

AU - Wagner, Henry N.

PY - 1999/4

Y1 - 1999/4

N2 - Accurate assessment of lung carcinoma remains a significant clinical problem, often leading to surgical procedures without curative potential. PET with 18F-fluorodeoxyglucose (FDG) has shown promise in differentiating benign from malignant lesions and in staging the extent of disease, resulting in improved treatment at a significant cost savings. This multicenter prospective study used dual-detector coincidence imaging with FDG to categorize pulmonary lesions as benign or malignant. The goal of this study was to determine the sensitivity and specificity of dual-detector coincidence imaging of FDG in patients with pulmonary lesions who were scheduled to have a diagnostic procedure for histopathologic confirmation. Methods: A total of 96 patients with pulmonary lesions with a lesion size ranging from 1 to 7 cm with a mean of 3.44 cm based on their chest radiograph or CT scan were studied using FDG scans with a dual-detector coincidence detection system. An additional 24 patients were entered as control subjects. The studies of 120 subjects were interpreted in random order by three physicians experienced in the use of FDG in patients with lung cancer. Surgical pathology was used as the standard for identifying malignant lesions. Results: There was 94% agreement between the readers in the independent interpretation of the FDG studies. In the 96 patients with pulmonary lesions, FDG studies were 97% sensitive and 80% specific in identifying proven malignant lesions. Conclusion: The results of this prospective study provide evidence that dual- detector coincidence imaging with FDG provides an accurate, sensitive and specific means of diagnosing malignancy in patients with pulmonary lesions.

AB - Accurate assessment of lung carcinoma remains a significant clinical problem, often leading to surgical procedures without curative potential. PET with 18F-fluorodeoxyglucose (FDG) has shown promise in differentiating benign from malignant lesions and in staging the extent of disease, resulting in improved treatment at a significant cost savings. This multicenter prospective study used dual-detector coincidence imaging with FDG to categorize pulmonary lesions as benign or malignant. The goal of this study was to determine the sensitivity and specificity of dual-detector coincidence imaging of FDG in patients with pulmonary lesions who were scheduled to have a diagnostic procedure for histopathologic confirmation. Methods: A total of 96 patients with pulmonary lesions with a lesion size ranging from 1 to 7 cm with a mean of 3.44 cm based on their chest radiograph or CT scan were studied using FDG scans with a dual-detector coincidence detection system. An additional 24 patients were entered as control subjects. The studies of 120 subjects were interpreted in random order by three physicians experienced in the use of FDG in patients with lung cancer. Surgical pathology was used as the standard for identifying malignant lesions. Results: There was 94% agreement between the readers in the independent interpretation of the FDG studies. In the 96 patients with pulmonary lesions, FDG studies were 97% sensitive and 80% specific in identifying proven malignant lesions. Conclusion: The results of this prospective study provide evidence that dual- detector coincidence imaging with FDG provides an accurate, sensitive and specific means of diagnosing malignancy in patients with pulmonary lesions.

KW - F-fluorodeoxyglucose

KW - Dual-detector coincidence imaging

KW - Solitary pulmonary lesions

UR - http://www.scopus.com/inward/record.url?scp=0032930912&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032930912&partnerID=8YFLogxK

M3 - Article

C2 - 10210215

AN - SCOPUS:0032930912

VL - 40

SP - 574

EP - 578

JO - Journal of Nuclear Medicine

JF - Journal of Nuclear Medicine

SN - 0161-5505

IS - 4

ER -